D
Daniela Concolino
Researcher at Magna Græcia University
Publications - 124
Citations - 2388
Daniela Concolino is an academic researcher from Magna Græcia University. The author has contributed to research in topics: Enzyme replacement therapy & Fabry disease. The author has an hindex of 24, co-authored 116 publications receiving 1940 citations.
Papers
More filters
Journal ArticleDOI
A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency
TL;DR: The insulin-like growth factors (IGFs; somatomedins) comprise a family of peptides that play important roles in mammalian growth and development and the principal members of this family are IGF1 and IGF2.
Journal ArticleDOI
DPM2-CDG: A muscular dystrophy–dystroglycanopathy syndrome with severe epilepsy
Rita Barone,Chiara Aiello,Valerie Race,Eva Morava,François Foulquier,Moniek Riemersma,Chiara Passarelli,Daniela Concolino,Massimo Carella,Filippo M. Santorelli,Wendy Vleugels,Eugenio Mercuri,Domenico Garozzo,Luisa Sturiale,Sonia Messina,Jaak Jaeken,Agata Fiumara,Ron A. Wevers,Enrico Bertini,Gert Matthijs,Dirk Lefeber +20 more
TL;DR: There was clinical evidence of a muscular dystrophy–dystroglycanopathy syndrome, supported by deficient O‐mannosylation by muscle immunohistochemistry, in 3 children from 2 families with a severe neurological phenotype.
Journal ArticleDOI
Targeted Next-Generation Sequencing Appoints C16orf57 as Clericuzio-Type Poikiloderma with Neutropenia Gene
Ludovica Volpi,Gaia Roversi,Elisa Colombo,Nico Leijsten,Daniela Concolino,Andrea Calabria,Maria Antonietta Mencarelli,Michele Fimiani,Fabio Macciardi,Rolph Pfundt,Eric F.P.M. Schoenmakers,Lidia Larizza +11 more
TL;DR: Next-generation sequencing is a straightforward tool for the identification of disease genes in extended genomic regions on a five-generation inbred Italian family with three siblings affected with Clericuzio-type poikiloderma with neutropenia, a rare autosomal-recessive genodermatosis characterised by poikILoderma, pachyonychia, and chronic neutropania.
Journal ArticleDOI
Enzyme replacement therapy: efficacy and limitations.
TL;DR: While ERT is effective in reducing urinary glycosaminoglycans and liver and spleen volume, cartilaginous organs such as the trachea and bronchi, bones and eyes are poorly impacted by ERT probably due to limited penetration in the specific tissue.
Journal ArticleDOI
Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy
Renzo Manara,Elena Priante,M Grimaldi,Lucia Santoro,Luca Astarita,Rita Barone,Daniela Concolino,Maja Di Rocco,Maria Alice Donati,Simona Fecarotta,Anna Ficcadenti,Agata Fiumara,Francesca Furlan,Irene Giovannini,Franco Lilliu,Rodica Mardari,Gabriele Polonara,Elena Procopio,Angelica Rampazzo,Andrea Rossi,Graziolina Sanna,Rossella Parini,Maurizio Scarpa +22 more
TL;DR: The spectrum of brain and spine MRI abnormalities in Hunter disease is extremely wide and requires a thorough evaluation and WMAs, atrophy/communicating hydrocephalus and spinal stenosis progress over time and might represent possible disease severity markers for new treatment efficacy assessment.